Showing results (151-160 of 186) with videos related to
Sort By:
Pageof 19
Clinical Cardiology|May 22, 1998
Management strategies for a better outcome in unstable coronary artery diseaseR W Campbell, L Wallentin, F W Verheugt, et al.Thrombosis and Haemostasis|April 1, 2000
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimerP S Wells, D R Anderson, M Rodger, et al.Journal of Thrombosis and Haemostasis : JTH|October 21, 2009
Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot studyY-K Kim, R Nieuwlaat, S J Connolly, et al.Circulation|March 14, 2001
Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS)B J O'Brien, S J Connolly, R Goeree, et al.Lancet (London, England)|September 12, 2001
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trialP M Bath, E Lindenstrom, G Boysen, et al.The American Journal of Cardiology|November 11, 1998
The Canadian Registry of Atrial Fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillationC R Kerr, J Boone, S J Connolly, et al.Journal of the American College of Cardiology|September 15, 2000
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary EventsS G Goodman, M Cohen, F Bigonzi, et al.Circulation|October 12, 1999
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trialE M Antman, C H McCabe, E P Gurfinkel, et al.Circulation|October 3, 2001
Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator studyR Sheldon, B J O'Brien, G Blackhouse, et al.Journal of Thrombosis and Haemostasis : JTH|April 2, 2015
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN StudyC W Francis, C M Kessler, S Z Goldhaber, et al.Pageof 19